K-PIO Tablets
For the use of a Registered Medical Practitioner, a Hospital or a Laboratory only.
COMPOSITION
K-PIO 15 mg Tablets
Each Uncoated Tablet Contains:
Pioglitazone HCl IP eq. to Pioglitazone 15 mg
 
K-PIO 30 mg Tablets
Each Uncoated Tablet Contains:
Pioglitazone HCl IP eq. to Pioglitazone 30 mg
 
INDICATIONS
K-PIO is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes (non-insulin-dependent diabetes mellitus, NIDDM). K-PIO is indicated for monotherapy. K-PIO is also indicated for use in combination with a sulfonylurea, metformin, or insulin when diet and exercise plus the single agent does not result in adequate glycemic control.
DOSAGE AND ADMINISTRATION
Oral: The recommended dose for K-PIO is 15-45 mg once daily without regard to meals.

HOW SUPPLIED
10 Tablets per strip.